➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Baxter
Express Scripts
Dow
Medtronic

Last Updated: September 22, 2020

DrugPatentWatch Database Preview

ZONISAMIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Zonisamide, and what generic alternatives are available?

Zonisamide is a drug marketed by Ani Pharms Inc, Apotex Inc, Aurobindo Pharma Ltd, Bionpharma Inc, Celltrion, Epic Pharma Llc, Glenmark Generics, Heritage Pharma, Invagen Pharms, Mylan, Mylan Pharms Inc, Roxane, Sun Pharm Inds (in), Sun Pharm Industries, Upsher Smith Labs, and Zydus Pharms Usa. and is included in seventeen NDAs.

The generic ingredient in ZONISAMIDE is zonisamide. There are nineteen drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the zonisamide profile page.

US ANDA Litigation and Generic Entry Outlook for Zonisamide

A generic version of ZONISAMIDE was approved as zonisamide by APOTEX INC on December 22nd, 2005.

  Start Trial

Drug patent expirations by year for ZONISAMIDE
Drug Prices for ZONISAMIDE

See drug prices for ZONISAMIDE

Drug Sales Revenue Trends for ZONISAMIDE

See drug sales revenues for ZONISAMIDE

Recent Clinical Trials for ZONISAMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Foundation for a Smoke-Free WorldPhase 3
Rose Research Center, LLCPhase 3
Ain Shams UniversityN/A

See all ZONISAMIDE clinical trials

US Patents and Regulatory Information for ZONISAMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds (in) ZONISAMIDE zonisamide CAPSULE;ORAL 077634-002 Mar 17, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan ZONISAMIDE zonisamide CAPSULE;ORAL 077637-002 Dec 22, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
Zydus Pharms Usa ZONISAMIDE zonisamide CAPSULE;ORAL 077625-001 Oct 16, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Sun Pharm Industries ZONISAMIDE zonisamide CAPSULE;ORAL 077635-003 Dec 22, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
Zydus Pharms Usa ZONISAMIDE zonisamide CAPSULE;ORAL 077625-002 Oct 16, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Invagen Pharms ZONISAMIDE zonisamide CAPSULE;ORAL 077869-001 May 31, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan ZONISAMIDE zonisamide CAPSULE;ORAL 077637-003 Dec 22, 2005 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Merck
Boehringer Ingelheim
Johnson and Johnson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.